Lv1
28 积分 2024-02-20 加入
Drug Disposition in Cystic Fibrosis
1天前
待确认
Control of Malabsorption in Cystic Fibrosis
1天前
已完结
Sublingual Tacrolimus for Immunosuppression in Lung Transplantation
1天前
已完结
Contribution of CYP3A5 to the in Vitro Hepatic Clearance of Tacrolimus
3天前
已完结
Physiologically-based pharmacokinetic modeling to predict the exposure and provide dosage regimens of Tacrolimus in Pregnant Women with infection disease
8天前
已完结
EFFECT OFCYP3A5POLYMORPHISM ON TACROLIMUS METABOLIC CLEARANCE IN VITRO
8天前
已完结
Physiologically Based Pharmacokinetic Modeling to Refine Dosing of Posaconazole in Young Children
14天前
已完结
Physiologically based pharmacokinetic model for oxcarbazepine active metabolite to predict pharmacokinetics in paediatric patients with renal impairment and adjust dosages
14天前
已关闭
Good Practices in Model‐Informed Drug Discovery and Development: Practice, Application, and Documentation
27天前
已完结
Clinical Exploration and Physiologically Based Modelling of the Impact of Hepatic Impairment on Entrectinib Pharmacokinetics
1个月前
已关闭
皖公网安备34019202002308
